DIAGENS-B

Hangzhou Deshi Biotechnology Co., Ltd. (hereinafter referred to as "Deshi Biotechnology") is a global leader in the fields of medical imaging AI and medical imaging equipment, with operations spanning the worldwide market. Leveraging its independently developed general-purpose medical imaging foundation model, iMedImage, the company has successfully built a diversified portfolio of intelligent imaging devices and supporting solutions, including the AutoVision Chromosome Karyotyping System, the MetaSight Automated Cell Microscopy Image Scanning System, the KayoFlow Automated Cell Harvesting and Slide Preparation–Staining Integrated System, and others—each designed to meet the diverse needs of clinical settings. The company's customer base now encompasses more than 400 healthcare centers and medical institutions across China, earning widespread market recognition. Looking ahead, Deshi Biotechnology will continue to provide global customers with standardized intelligent imaging equipment, a Model-as-a-Service (MaaS) cloud platform, and localized self-training solutions, leveraging technological innovation to enhance the efficiency, accuracy, and accessibility of medical imaging diagnostics and thereby spearheading the global medical imaging industry into the era of intelligence.